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Abstract 
This study explores the relationship between hospital costs and quality of care for Acute Myocardial 
Infarction (AMI) in the Edmonton area hospitals. The importance of this relationship is realized when 
policy makers face decisions about cost minimization and quality maximization during times of health 
care budget constraints. This study uses regression modelling with increasing specifications as well as 
various robustness checks to ensure the accuracy of the results. The Model specifications include 
demographics, AMI risk adjustments, Hospital fixed effects, and year fixed effects. Semi-parametric 
regression removes the assumption of linearity to determine the true relationship between hospital cost 
and AMI quality. Higher AMI quality is associated with a 39% increase in hospital costs after 
adjustments and controls. The semi-parametric regression shows a fairly linear relationship between 
cost and AMI quality. This study suggests that Canadian policy and decision makers should take 
caution during budget cuts and implementing cost containment programs. The results suggest that 
reducing AMI budgets may have a negative effect on the quality of AMI care patients receive in 
Edmonton, Alberta. The linear relationship suggests that the return on the quality of AMI is consistent 
for each dollar invested with no economies of scale. 
Keywords 
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1. Introduction 
The relationship between quality of care and cost is essential to all policy makers. This study explores 
the relationship between hospital costs and quality of care for Acute Myocardial Infarction (AMI) in 
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the Edmonton area hospitals. This relationship is increasingly important for policy makers who have 
strict budget constraints and make decisions about cost minimization and quality maximization. To our 
knowledge this is the first Canadian study on the cost-outcome tradeoff for AMI. 
Cost-outcome tradeoff studies are focused on either outcome on cost (Hvenegaard, Arendt, Street, & 
Gyrd-Hansen, 2011; Gutacker et al., 2013) or cost on outcome (Fisher et al., 2003; Fisher, Wennberg, 
Stukel, & Gottlieb, 2004 Variations Supplement; Kaestner & Silber, 2010; Schreyögg & Stargardt, 
2010; Romley, Jena, & Goldman, 2011; Stargardt, Schreyögg, & Kondofersky, 2014; Häkkinen et al., 
2014; Häkkinen, Rosenqvist, Iversen, Rehnberg, & Seppälä, 2015 Supplement). The Canadian health 
care system is complex where the hospitals receive mainly global funding from the province while 
physicians bill the provinces after providing their services. Due to this complexity it is unclear on 
which methodology should be applied to the Canadian system. 
Recent observational outcome-cost tradeoff studies have tried to control for unobservable variable and 
reverse causality bias through Instrumental Variable (IV) regression modelling (Kaestner & Silber, 
2010; Stargardt, Schreyögg, & Kondofersky, 2014; Häkkinen, Rosenqvist, Iversen, Rehnberg, & 
Seppälä, 2015 Supplement; Schreyögg & Stargardt, 2010). The IV models require a variable (the 
instrument) that is highly correlated with the dependent variable (hospital costs) and must have no 
relationship with the explanatory variable (quality of AMI care) to ensure a non-bias estimate of causal 
effects. Instruments from previous studies include: total inpatient spending per decedent (Kaestner & 
Silber, 2010), average hospital costs in federal state and price per square meter in hospitals in the 
country (Stargardt, Schreyögg, & Kondofersky, 2014), Hospital level average cost of unstable angina 
(Häkkinen, Rosenqvist, Iversen, Rehnberg, & Seppälä, 2015 Supplement), and Hospital occupancy rate 
(Schreyögg & Stargardt, 2010). However, these previous IV’s cannot be used in this study due to this 
studies small and well-defined sample population.  
This study focuses on the quality and cost of AMI care for Edmonton, Alberta, Canada. There are 
several advantages in this well-defined population. The first reason is that AMI requires immediate 
medical attention, which removes problems with patient selections between hospitals. The second is 
that hospitals that provide better care can substantially improve the quality relating to AMI (Stargardt, 
Schreyögg, & Kondofersky, 2014). The third is that the quality of care can be measured by mortality in 
well-defined patient groups (Häkkinen, Rosenqvist, Iversen, Rehnberg, & Seppälä, 2015 Supplement). 
Lastly, the existence of any possible relationship between quality and cost may differ between different 
heterogeneous sample groups such as the difference between cities, provinces, and countries, which 
may explain the inconsistent findings in existing literatures.  
Some studies in the United States have found a positive association where higher cost leads to a better 
outcome (Timbie, Newhouse, Rosenthal, & Normand, 2008; Schreyögg & Stargardt, 2010; Romley, 
Jena, & Goldman, 2011) while other studies from United States found no association (Fisher et al., 
2003; Fisher, Wennberg, Stukel, & Gottlieb, 2004 Variations Supplement; Jha, Orav, Dobson, Book, & 
Epstein, 2009; Yasaitis, Fisher, Skinner, & Chandra, 2009; Kaestner & Silber, 2010; Hussey, 
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Wertheimer, & Mehrotra, 2013). Besides our neighboring country, these inconsistent results also exist 
across the globe where a positive relationship was found in Sweden (Häkkinen et al., 2014), Hungry, 
Finland (Häkkinen, Rosenqvist, Iversen, Rehnberg, & Seppälä, 2015 Supplement) and Germany 
(Stargardt, Schreyögg, & Kondofersky, 2014). No clear evidence of any association was also found for 
Finland, France, Germany, and Spain (Häkkinen et al., 2014). 
 
2. Data and Method 
2.1 Data 
In this study all micro-costing data comes from the Management Information System (MIS) from 
Alberta Health Services (AHS). These costs include all functional costs such as hospital direct cost, 
hospital drug cost, patient supply cost, patient drug cost, and hospital indirect cost. Hospital discharge 
data were available for 4802 AMI (ICD-10 code I21) patients in the Edmonton area hospitals between 
fiscal periods of April 1, 2006 to March 30, 2009. Patients were excluded if they were discharged as a 
transfer to an acute care facility, left against medical advice, or had a Length of Stay (LOS) greater than 
90 days (3988 patients remaining). We also excluded patients who were hospitalized for AMI within 
one-year prior the index day to restrict our analysis to only new AMI hospitalization (3554 patients 
remaining). All functional costs are aggregated for each patient. The data set also contains Resource 
Intensity Weights (RIW’s) and the Case Mixed Group Plus (CMG+) which allows a linkage to the 
Canadian Institute for Health Information (CIHI) costing proxy. This is used as a robustness check and 
is further explained in the robustness check section.  
Similar to previous studies (Häkkinen, Rosenqvist, Iversen, Rehnberg, & Seppälä, 2015 Supplement), 
the quality indicator is a binary variable measured by a 30-day survival where it takes a value of 1 if the 
patient is alive after 30 days and 0 if the patient died during the 30 days. It has been argued and shown 
that within a well-defined patient group such as AMI, the quality or outcome of hospital care is 
measureable by hospital mortality in many countries such as Canada, Denmark, United Kingdom, 
United States, Sweden, and Finland (Häkkinen, Rosenqvist, Iversen, Rehnberg, & Seppälä, 2015 
Supplement). Risk adjustment is controlled with binary variables for 15 comorbidities (Note 1). 
Demographic controls include both age and sex. Hospital fixed effects will account for hospital 
heterogeneity such as teaching or university status. Year fixed effects will account for any annual 
fluctuations in policy or economic conditions.  
2.2 Methods 
2.2.1 Parametric Analysis 
Hospital costs were regressed with increasing model specifications starting with a simple linear 
regression of just hospital costs and quality (equation 1). The second model has additional demographic 
controls (equation 2). The third model includes risk adjustments (equation 3). The last two models 
include hospital fixed effects (equation 4) and year fixed effects (equation 5). Where i is the ith patient 
treated at time t, 𝑪𝑶𝑺𝑻, is the micro-costing data from MIS, Q is the respective quality measurement 
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as defined above, 𝑿 is a vector of demographic controls, 𝑹 is a vector of risk adjustments, 𝑯𝒐𝒔 is 
hospital fixed effects, 𝒀𝒆𝒂𝒓 is year fixed effects, and 𝜺 is the residuals. All costs are logarithmically 
transformed to create a normal distribution and make easier interpretation of the results for policy 
makers and layman research users.  
𝒍𝒏𝑪𝑶𝑺𝑻𝒊,𝒕 = 𝜷𝟏𝑸𝒊,𝒕 +𝜺𝒊,𝒕                             (1) 
𝒍𝒏𝑪𝑶𝑺𝑻𝒊,𝒕 = 𝜷𝟏𝑸𝒊,𝒕 + 𝜷𝟐𝑿𝒊,𝒕+ + 𝜺𝒊,𝒕                        (2) 
𝒍𝒏𝑪𝑶𝑺𝑻𝒊,𝒕 = 𝜷𝟏𝑸𝒊,𝒕 + 𝜷𝟐𝑿𝒊,𝒕+ 𝜷𝟑𝑹𝒊,𝒕 + 𝜺𝒊,𝒕                     (3) 
𝒍𝒏𝑪𝑶𝑺𝑻𝒊,𝒕 = 𝜷𝟏𝑸𝒊,𝒕 + 𝜷𝟐𝑿𝒊,𝒕+ 𝜷𝟑𝑹𝒊,𝒕 + 𝜷𝟒𝑯𝒐𝒔𝒊,𝒕 + 𝜺𝒊,𝒕              (4) 
𝒍𝒏𝑪𝑶𝑺𝑻𝒊,𝒕 = 𝜷𝟏𝑸𝒊,𝒕 + 𝜷𝟐𝑿𝒊,𝒕+ 𝜷𝟑𝑹𝒊,𝒕 + 𝜷𝟒𝑯𝒐𝒔𝒊,𝒕 +  𝜷𝟓𝒀𝒆𝒂𝒓𝒊,𝒕 + 𝜺𝒊,𝒕         (5) 
2.2.2 Semi-Parametric Analysis 
If evidence of an association exists, then it is important for policy makers to know the true functional 
form of the relationship between quality and hospital costs. Semi-parametric regressions allowed us to 
relax the assumption of linearity from multi-linear regression analysis. Our model will resume the use 
of the linearity assumption on all parameters except the quality measurement as shown in equation 6, 
where F is an unknown function and the 𝑸𝒊,𝒕 coefficient remains linear. This function will be depicted 
in a graphical form to allow the interpretation of its true functional form.  
𝒍𝒏𝑪𝒊,𝒕 = 𝑭(𝑸𝒊,𝒕) + 𝜷𝟏𝑿𝒊,𝒕+ 𝜷𝟐𝑹𝒊,𝒕 +  𝜷𝟑𝑯𝒐𝒔𝒊,𝒕 +  𝜷𝟒𝒀𝒆𝒂𝒓𝒊,𝒕 + +𝜺𝒊,𝒕          (6) 
 
3. Results 
Table 1 contains descriptive statistics broken down by sex for selected variables. The average age was 
69 and 77 for males and females, respectively. There were approximately twice as many males than 
females. Male patients have increased drastically from fiscal year 2007 to fiscal year 2009. There were 
1377 male and 470 female patients who received Percutaneous Coronary Intervention, which is a 
non-invasive and less expensive procedure compared to a Coronary Artery Bypass Grafting (CABG). 
11 male patients received CABG compared to only 1 female. 43 male patients signed-out against 
medical advice compared to 11 female patients.  
 
Table 1. Descriptive Statistics 
    Fiscal Year1 
 
Male (n=2421) 2006/2007 2007/2008 2008/2009 
(1) Age 72 (14) 70 (14) 68 (13) 
(2) Length of Stay 7.8 (6.7) 7.3 (6.6) 6.7 (5.6) 
(3) Cost $11,463 (10496) $10,684 (9554) $11,650 (11109) 
(4) CABG (#) 11 0 0 
(5) PCI (#) 277 515 585 
 
Female (n=1133) 
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(6) Age (mean) 81 (14) 76 (14) 76 (14) 
(7) Length of Stay (mean) 10.2 (10.8) 8.9 (8.9) 8.2 (7.80 
(8) Cost (mean) $12,287 (13175) $11,026 (8450) $12,377 (9804) 
(9) CABG (#) 1 0 0 
(10) PCI (#) 91 191 188 
Note. 1 Fiscal period starts in April Ends in March. 
Standard Deviation in Brackets when applicable. 
 
All the results from the regression models with increasing regression specifications are shown in table 
two. The results suggest that the quality of AMI care as measured by hospital mortality is positively 
associated with hospital costs after controlling for demographics, comorbidities, and fixed effects. These 
results suggest that higher AMI quality of care is associated with approximately 39% higher hospital 
costs.  
 
Table 2. Select AMI Quality Regression Coefficients 
    (1) (2) 
 
Model Specifications Quality Coefficents1 Survival Coefficients 
(1) No Risk adjustment .393*** 0.087*** 
(2) + Risk adjustments .391*** .093*** 
(3) + Hospital Fixed Effects .399*** .091*** 
(4) + Year Fixed Effects .388*** 0.092*** 
(6) Instrumental Variable regression -8.308 1.918 
(7) 1st Stage F-Stat 20.97 52.91 
(8) Instrumental Variable regression2  -2.440 -0.654 
(9) 1st Stage F-Stat 17.54 43.67 
Note. *, **, *** indicates 1%, 5%, 10%, significance levels respectively. 
1 Based on patient mortality. 
2 Controlled for: average household income, prevalence of current smoking, average HUI3 index, and 
average number of drinks per day. 
 
The semi-parametric regression results (Figure 1) show a fairly linear and positive relationship between 
the numbers of days survived and hospital costs. This provides additional support for the positive 
association found under the parametric approach.  
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Figure 1. Functional Form of Quality vs. Cost from Semi-Parametric Regression with 95% 
Confidence Interval 
 
4. Robustness Check 
Following the CIHI methodology for CMG+ cost estimation each patient’s RIW was multiplied with 
the provincial CPWC from years 2006/2007 to 2008/2009. However due to changes in CIHI 
procedures these CPWC are no longer publicly available. This study will include these CPWC for 
future references (Note 2). To ensure further robustness of our results, this study replaces all 
micro-costs used in the previous analysis with the CMG+ cost estimates. The association under all 
specification were consistent with the previous findings when using the CMG+ cost estimates. All 
robustness check results are available upon request from the corresponding author. 
 
5. Conclusion and Discussion 
This study cautions Canadian policy and decision makers on budget cuts and cost containment 
programs relating to AMI. Our model finds evidence of a robust positive association between the level 
of AMI care and hospital cost. In other words, reducing hospital expenditure is associated with a 
decrease in AMI quality for Edmonton, Alberta. These results suggest that policy makers should take 
extreme caution when implementing any cost containment program as it may have a negative effect on 
patient health.  
These results have undergone various robustness checks including increasing model specifications and 
replacing the micro-costing data with CMG+ cost estimates. These variations ensured the robustness of 
a positive association between the quality of AMI care and hospital costs. Similar positive association 
between AMI quality and hospital costs can be found in studies from California (Romley, Jena, & 
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Goldman, 2011), Germany (Stargardt, Schreyögg, & Kondofersky, 2014), Sweden (Häkkinen et al., 
2014), and United States Veterans hospitals (Schreyögg & Stargardt, 2010). Interestingly, this study’s 
semi-parametric approach confirms a fairly linear relationship between quality and cost, which suggest 
that economics of scale and diminishing marginal returns may not be applicable. This means that the 
return on the quality of AMI is constant for each dollar invested.  
Two major strengths of this study lie in the data set used. The first is that the data set is population 
based and not a sample. This data set contains all patients between fiscal years 2006 to 2009 who were 
admitted for AMI in Edmonton Alberta. The second, is that all costs came from the Alberta Health 
Services MIS which contains actual patient costs that remove the need for further estimation of costs.  
 
6. Limitations 
A major limitation in all AMI outcome-cost studies is the definition of quality being used. An ideal 
study would need to incorporate some true measure of AMI quality instead of the quality proxy. To our 
knowledge, there are no measures of the true quality of AMI and to derive such measurement would 
require the help of experts and physicians in AMI care. Other limitation includes that AMI treatment 
like PCI and CABG may be done after the initial hospitalization and in another hospital and 
increasingly also as outpatient operation. This may have impact to our cost and procedure outcomes of 
the study. 
This study is restricted to the Edmonton area hospitals, which may reduce the variations between cost 
and quality indicators. A higher-level provincial study would be needed to provide more insight on the 
nature between hospital cost and AMI quality. This study also suffers from the inability to control for 
unobservable variable bias and reverse causality. This study has explored all previously proposed IV’s 
as well as health area-based instrumentations (Chu & Ohinmaa, 2016), which were not possible to use 
since the majority of patients were from the same health region.  
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Notes 
Note 1. Hypertension, Diabetes Mellitus, Cancer, COPD (Chronic Obstructive Pulmonary Disease) and 
Asthma, Dementia, Depression, Parkinson’s disease, Mental Disorders, Renal Insufficiency, 
Alcoholism, Coronary Artery disease, Atrial Fibrillation, Cardiac Insufficiency (heart failure), 
Atherosclerosis, and Stroke. 
Note 2. Provincial CPWC values for fiscal years 06/07, 07/08, and 08/09 are $5541.24, $6152.33, and 
$5769.08, respectively. 
 
